Tolerance.ca
Directeur / Éditeur: Victor Teboul, Ph.D.
Regard sur nous et ouverture sur le monde
Indépendant et neutre par rapport à toute orientation politique ou religieuse, Tolerance.ca® vise à promouvoir les grands principes démocratiques sur lesquels repose la tolérance.

COVID: new antibody treatment could offer up to 18 months' protection against severe disease

(Version anglaise seulement)
par Rebecca Aicheler, Senior Lecturer in Immunology, Cardiff Metropolitan University
Partagez cet article
A new treatment could soon help protect people from developing severe COVID. AstraZeneca has just released results from a phase 3 clinical trial – the final stage of testing before a drug is authorised – that suggest its new COVID treatment, AZD7442, is effective at reducing severe disease or death in non-hospitalised COVID patients.

The treatment contains…The Conversation


Lire l'article complet

© La Conversation -


Suivez-nous sur ...
Facebook Twitter